Add to ORKGOverall Goals and Objectives: 1. Understand the risk factors for Bronchiolitis Obliterans Syndrome after lung transplantation 2. Be familiar with recent developments in the therapy of Bronchiolitis Obliterans Syndrome 3. Be aware of strategies for prevention
BACKGROUND: Lung transplant (LTx) recipients have low long-term survival and a high incidence of bro...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
The diagnosis of the obliterative bronchiolitis syndrome in lung transplantation is presently best e...
Overall Goals and Objectives: 1. Understand the risk factors for Bronchiolitis Obliterans Syndrome a...
With a prevalence of 34% (55/162 at-risk recipients) and a mortality of 25% (14/55 affected recipien...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Lung transplantation remains the only effective therapeutic option for well-selected patients with e...
The development of chronic lung allograft dysfunction (CLAD) is one of the major obstacles following...
Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is asso...
Lung transplantation is currently the only available treatment for endstage lung disease patients. D...
ObjectivesIn 2005, the time-based waiting list for lung transplantation was replaced by an illness/b...
Although allogeneic hematopoietic stem cell transplant (allo-HSCT) is performed to treat otherwise i...
Post-transplant bronchiolitis obliterans, also called bronchiolitis obliterans syndrome, affects up ...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
BACKGROUND: Lung transplant (LTx) recipients have low long-term survival and a high incidence of bro...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
The diagnosis of the obliterative bronchiolitis syndrome in lung transplantation is presently best e...
Overall Goals and Objectives: 1. Understand the risk factors for Bronchiolitis Obliterans Syndrome a...
With a prevalence of 34% (55/162 at-risk recipients) and a mortality of 25% (14/55 affected recipien...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Lung transplantation remains the only effective therapeutic option for well-selected patients with e...
The development of chronic lung allograft dysfunction (CLAD) is one of the major obstacles following...
Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is asso...
Lung transplantation is currently the only available treatment for endstage lung disease patients. D...
ObjectivesIn 2005, the time-based waiting list for lung transplantation was replaced by an illness/b...
Although allogeneic hematopoietic stem cell transplant (allo-HSCT) is performed to treat otherwise i...
Post-transplant bronchiolitis obliterans, also called bronchiolitis obliterans syndrome, affects up ...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
BACKGROUND: Lung transplant (LTx) recipients have low long-term survival and a high incidence of bro...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
The diagnosis of the obliterative bronchiolitis syndrome in lung transplantation is presently best e...